ConductScience.org, home

Paper2391382

Hybrids from fusion of normal human T lymphocytes with immortal human cells exhibit limited life span.

Pereira-Smith OM and 3 others. J Cell Physiol, 1990. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Hybrids from fusion of normal human T lymphocytes with immortal human cells exhibit limited life span. Papers, record 2391382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2391382

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hybrids from fusion of normal human T lymphocytes with immortal human cells exhibit limited life span.
PubMed
Journal
J Cell Physiol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.56
iCite
Revised in PubMed
2007-11-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pereira-Smith OMO M
2Robetorye SS
3Ning YY
4Orson FMF M

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibroblastsMajor topic
Hybrid CellsMajor topic
T-LymphocytesMajor topic
Adult
Cell Division
Cell Fusion
Cell Line, Transformed
Humans

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AG05333NIA NIH HHSUnited StatesR01AG005333PubMed and NIHNIH RePORTER
AG07068NIA NIH HHSUnited StatesR01AG007068PubMed and NIHNIH RePORTER
P01-AGO7123NIA NIH HHSUnited StatesPubMedPubMed
P01AG007123NIHNIH RePORTER
R37AG005333NIHNIH RePORTER

Download CSV of grants

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
17990793Exploring the native human antibody repertoire to create antiviral therapeutics.Curr Top Microbiol Immunol2008https://conductscience.org/library/papers/17990793PubMed
11850815Differential protein expression, DNA binding and interaction with SV40 large tumour antigen implicate the p63-family of proteins in replicative senescence.Oncogene2002https://conductscience.org/library/papers/11850815PubMed
9545418The genetics of cellular senescence.Am J Hum Genet1998https://conductscience.org/library/papers/9545418PubMed
8139534A gene involved in control of human cellular senescence on human chromosome 1q.Mol Cell Biol1994https://conductscience.org/library/papers/8139534PubMed
7604871Human replicative senescence. A molecular study.Am J Pathol1995https://conductscience.org/library/papers/7604871PubMed
2062841Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/2062841PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2391382

GET https://conductscience.org/api/papers/v1/2391382/authors